Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-inflammatory effects of montelukast in mild cystic fibrosis.
Schmitt-Grohé S, Eickmeier O, Schubert R, Bez C, Zielen S. Schmitt-Grohé S, et al. Among authors: eickmeier o. Ann Allergy Asthma Immunol. 2002 Dec;89(6):599-605. doi: 10.1016/S1081-1206(10)62108-4. Ann Allergy Asthma Immunol. 2002. PMID: 12487226 Clinical Trial.
Granular cell tumor of the trachea in a child.
Stieglitz F, Kitz R, Schäfers HJ, Eickmeier O, Rose M, Fellbaum C, Zielen S. Stieglitz F, et al. Among authors: eickmeier o. Ann Thorac Surg. 2005 Feb;79(2):e15-6. doi: 10.1016/j.athoracsur.2003.12.094. Ann Thorac Surg. 2005. PMID: 15680798
Montelukast as add-on therapy to beta-agonists and late airway response.
Rosewich M, Rose MA, Eickmeier O, Travaci M, Kitz R, Zielen S. Rosewich M, et al. Among authors: eickmeier o. Eur Respir J. 2007 Jul;30(1):56-61. doi: 10.1183/09031936.00063106. Epub 2007 Feb 14. Eur Respir J. 2007. PMID: 17301091 Free article. Clinical Trial.
[Pro-resolving lipid mediators in inflammatory lung diseases].
Eickmeier O, Hilberath JN, Zielen S, Haworth O. Eickmeier O, et al. Pneumologie. 2011 Mar;65(3):149-58. doi: 10.1055/s-0030-1255913. Epub 2010 Nov 29. Pneumologie. 2011. PMID: 21117020 Free article. Review. German.
The chitinase-like protein YKL-40 modulates cystic fibrosis lung disease.
Hector A, Kormann MS, Mack I, Latzin P, Casaulta C, Kieninger E, Zhou Z, Yildirim AÖ, Bohla A, Rieber N, Kappler M, Koller B, Eber E, Eickmeier O, Zielen S, Eickelberg O, Griese M, Mall MA, Hartl D. Hector A, et al. Among authors: eickmeier o. PLoS One. 2011;6(9):e24399. doi: 10.1371/journal.pone.0024399. Epub 2011 Sep 20. PLoS One. 2011. PMID: 21949714 Free PMC article.
CXCR1 and CXCR2 haplotypes synergistically modulate cystic fibrosis lung disease.
Kormann MS, Hector A, Marcos V, Mays LE, Kappler M, Illig T, Klopp N, Zeilinger S, Carevic M, Rieber N, Eickmeier O, Zielen S, Gaggar A, Moepps B, Griese M, Hartl D. Kormann MS, et al. Among authors: eickmeier o. Eur Respir J. 2012 Jun;39(6):1385-90. doi: 10.1183/09031936.00130011. Epub 2011 Nov 16. Eur Respir J. 2012. PMID: 22088968 Free article.
49 results